EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Maximizing therapeutic potential and safety: Exploring multi/dual-payload antibody conjugates as cancer theranostics

Meysam Khosravifarsani, Fabrice Ngoh Njotu, Dede Api Fon, Humphrey Fonge

Advanced Drug Delivery Reviews · 2025

DOI: 10.1016/j.addr.2025.115608 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2025. Verfasst von Meysam Khosravifarsani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Pharmacie, Université Laval, Ferdinand Vandry Pavillon, Québec, QC G1V 0A6, Canada; Axe Oncologie, Centre de Recherche du CHU de Québec-Un…. Hauptthemen laut MEDLINE: Neoplasms, Immunoconjugates, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Quebec Research Fund Nature and Technology, Canadian Institutes of Health Research, Fonds de recherche du Québec.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunoconjugatesAntineoplastic AgentsHumansAnimalsAntibodies, MonoclonalTheranostic NanomedicineImmunotherapy

Stichwörter der Autor:innen

Drug-to-antibody ratioDual and multiple payloadsHeterogeneityHuman equivalent doseSynergismTheranostics

Substanzen

ImmunoconjugatesAntibodies, MonoclonalAntineoplastic Agents

Autor:innen und Institutionen

  • Faculté de Pharmacie, Université Laval, Ferdinand Vandry Pavillon, Québec, QC G1V 0A6, Canada; Axe Oncologie, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1J 5B3 Canada.
  • Faculté de Pharmacie, Université Laval, Ferdinand Vandry Pavillon, Québec, QC G1V 0A6, Canada; Axe Oncologie, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1J 5B3 Canada. Electronic address: humphre…

Förderung

  • Quebec Research Fund Nature and Technology
  • Canadian Institutes of Health Research
  • Fonds de recherche du Québec
  • Institute of Cancer Research

Zitieren

APA

Khosravifarsani, M., Njotu, F. N., Fon, D. A., & Fonge, H. (2025). Maximizing therapeutic potential and safety: Exploring multi/dual-payload antibody conjugates as cancer theranostics. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2025.115608

Vancouver

Khosravifarsani M, Njotu FN, Fon DA, Fonge H. Maximizing therapeutic potential and safety: Exploring multi/dual-payload antibody conjugates as cancer theranostics. Advanced Drug Delivery Reviews. 2025. doi:10.1016/j.addr.2025.115608

BibTeX
@article{Khosravifarsani2025,
  author = {Khosravifarsani, Meysam and Njotu, Fabrice Ngoh and Fon, Dede Api and Fonge, Humphrey},
  title = {Maximizing therapeutic potential and safety: Exploring multi/dual-payload antibody conjugates as cancer theranostics},
  journal = {Advanced Drug Delivery Reviews},
  year = {2025},
  doi = {10.1016/j.addr.2025.115608}
}
Kostenlos starten →